Trade AbbVie ^ABBV

H.C. Wainwright Keeps Buy Rating on Oruka (ORKA) After Apogee Acquisition News

AbbVie Inc. (ABBV) Hits New Milestone with Venetoclax on Chronic Lymphocytic Leukemia (CLL) Treatment

AbbVie (ABBV) Faces Congressional Scrutiny Over China Clinical Trials

Regenxbio Shares Rise on $100 Million Milestone Payment After First Patient Dosed in Eye-Disease Trial | Morningstar

Erste Group Bank Has Negative View of AbbVie FY2027 Earnings

AbbVie Inc. $ABBV Shares Acquired by IFM Investors Pty Ltd

27,397 Shares in AbbVie Inc. $ABBV Acquired by Capricorn Fund Managers Ltd

Galderma Application for Product to Rival Botox Turned Down Again by FDA | Morningstar

Feasibility and safety of rapid glofitamab ramp-up

Wall Street Says to Buy These 3 Dividend Aristocrats

AbbVie (NYSE:ABBV) Shares Down 1.1% - Here's Why - Zolmax

Stocks bid on quarter end while bonds fall as focus shifts to data - Newsquawk US Market Wrap

5 Best Dividend Aristocrat Stocks To Buy Now

Merck, AbbVie probed by US lawmakers over China clinical trials: report

Promising Pharmaceutical Stocks To Research - June 30th - Stock Observer

Nxera Pharma Secures $10 Million Milestone Payment From AbbVie In Neurological Disease Collaboration

Forum Financial Management LP Reduces Stock Position in AbbVie Inc. $ABBV - Markets Daily

US Lawmakers Investigate Merck and AbbVie for Ties to China's Military Drug Trials, ETPharma

Erste Group Bank Has Negative View of AbbVie FY2026 Earnings

3 Stocks Estimated To Be Trading At A Discount Of Up To 48.9%

US House committee opens investigation into Merck, AbbVie China drug trials

Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases

Fresh millions swell Nxera haul from AbbVie alliance with a further $1.2bn in play

Is AbbVie (ABBV) One of the 10 Best July Dividend Stocks to Buy?

AbbVie (ABBV) Stock After 1-Year 41% Rally And Apogee Deal Valuation Check

2 S&P 500 Stocks with Promising Prospects and 1 We Find Risky

Union Bancaire Privee UBP SA Sells 67,022 Shares of AbbVie Inc. $ABBV

Promising Pharmaceutical Stocks To Watch Today - June 29th - Daily Political

Patton Fund Management Inc. Cuts Holdings in AbbVie Inc. $ABBV

Janney Montgomery Scott LLC Has $262.57 Million Stock Holdings in AbbVie Inc. $ABBV - Stock Observer

Pharm giant AbbVie acquires new company for $10B

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

AbbVie Receives Positive CHMP Opinion for Upadacitinib for the Treatment of Adults and Adolescents with Severe Alopecia Areata | INN

AbbVie Inc. $ABBV Shares Sold by Orange Investment Advisors Inc. - Daily Political

Going Back to the Well in a Sector That's Working

RBC Capital Maintains a Sector Perform Rating on Regeneron (REGN) - Here's Why

AbbVie Inc. $ABBV Stock Holdings Boosted by Venturi Wealth Management LLC

Sterling Capital Management LLC Sells 3,843 Shares of AbbVie Inc. $ABBV - Stock Observer

AbbVie (ABBV) Is Up 17.0% After EU MAVIRET Expansion And New Global Label Wins - What's Changed - Simply Wall St News

AbbVie (ABBV) Wins Health Canada Approval for Boey

AbbVie (ABBV) to Acquire Apogee Therapeutics

Medical Stocks To Follow Now - June 27th - Zolmax

Pharmaceutical Stocks To Research - June 27th - Daily Political

90,100 Shares in AbbVie Inc. $ABBV Bought by Louisiana State Employees Retirement System

AbbVie Inc. $ABBV Shares Sold by Aaron Wealth Advisors LLC

AbbVie (NYSE:ABBV) Upgraded by Wall Street Zen to Strong-Buy Rating

Barton Investment Management Has $1.65 Million Holdings in AbbVie Inc. $ABBV - Daily Political

SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric

AbbVie (NYSE:ABBV) Stock Price Up 3.4% - Here's What Happened

AbbVie's Skyrizi Gets FDA Approval For Pediatric Use | Morningstar

AbbVie says FDA approves Skyrizi for pediatric use in psoriatic disease

Healthcare stocks have become a haven for investors ditching tech | Morningstar

AbbVie (ABBV) Wins EU Approval For Pediatric Skyrizi And Broader Maviret Use

AbbVie On Pace For Record Closing High - Data Talk | Morningstar

Fidelity (FHLC) vs. iShares (IXJ): Which Healthcare ETF Delivers Better Value?

BTC Capital Management Inc. Increases Position in AbbVie Inc. $ABBV - Zolmax

AbbVie (NYSE:ABBV) Hits New 52-Week High - Here's What Happened - Daily Political

Blue Trust Inc. Reduces Stock Holdings in AbbVie Inc. $ABBV

Apella Capital LLC Raises Holdings in AbbVie Inc. $ABBV

Cardano Risk Management B.V. Sells 4,908,260 Shares of AbbVie Inc. $ABBV - Stock Observer

AbbVie Inc. (NYSE:ABBV) Receives Consensus Rating of "Moderate Buy" from Brokerages - Daily Political

Will AbbVie's (ABBV) Pediatric Expansions Reveal a Deeper Shift in Its Growth Mix?

AbbVie (NYSE:ABBV) Shares Up 3.7% - Should You Buy?

Miller Howard Investments Inc. NY Sells 3,294 Shares of AbbVie Inc. $ABBV

OP Asset Management Ltd Purchases Shares of 310,902 AbbVie Inc. $ABBV

AbbVie Stock Leads 3 Cash Flow Picks Trading Below Estimated Value

3 Psychedelic Stocks In The Space AbbVie Bet A Billion Dollars On

AbbVie Stock And 2 Cash Flow Picks Worth A Closer Look

Canaccord Says AbbVie's (ABBV) Apogee Deal Strengthens Long-Term Growth Outlook

Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial

AbbVie (NYSE:ABBV) Trading 6.3% Higher - Still a Buy? - Zolmax

Why I Can't Stop Buying This Unstoppable Dividend Juggernaut

AbbVie's $11 Billion Immunology Bet

FDA Complete Response Letter (CRL) Explained: What It Means For Biotech Stocks

64 Years Old With $1.1 Million in a Traditional IRA. Here's Where I'm Allocating Capital

BOTOX® Cosmetic (onabotulinumtoxinA) Introduces The Confidence Collective's Entrepreneur Class of 2026 | Morningstar

After Apogee, 3 More Biotech Buyout Targets Wall Street Can't Stop Watching - 24/7 Wall St.

AbbVie Inc. $ABBV Shares Acquired by Signal Advisors Wealth LLC

SVB Wealth LLC Sells 10,374 Shares of AbbVie Inc. $ABBV

Great Place To Work Reveals Southeast Asia's Best Workplaces™ in Healthcare & Biopharma

SVB Wealth LLC Reduces Position in AbbVie Inc. $ABBV - Daily Political

Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients

Apogee Therapeutics downgraded to Hold from Buy at TD Cowen

AbbVie Just Sparked a 46% Rally in Apogee. Here's Why This $10.9 Billion Deal Could Be a Win for AbbVie Investors.

Therapeutics Stocks Q1 Recap: Benchmarking Biogen (NASDAQ:BIIB)

AbbVie (NYSE:ABBV) Receives "Overweight" Rating from Piper Sandler - Markets Daily

AbbVie (NYSE:ABBV) Receives "Overweight" Rating from Piper Sandler - Zolmax

AbbVie (ABBV) Is Buying Apogee Therapeutics For $10.9 Billion To Rebuild Its Pipeline

AbbVie (ABBV) Gains EU Approval for Expanded Use of Hepatitis C Treatment Maviret

3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal

AbbVie (ABBV) Secures EU Approval for Skyrizi in Pediatric Psoriasis Treatment

Apogee Therapeutics (NASDAQ:APGE) Stock Rating Lowered by Citigroup - Zolmax

Apogee Therapeutics (NASDAQ:APGE) Stock Rating Lowered by Citigroup - Markets Daily

What is a Good P/E Ratio? Formula, Meaning & Trading Guide

What Is the VIX Volatility Index? A Trader’s Guide to Market Fear

Micron (MU) Stock Forecast: 2027, 2030, and 2045 Price Predictions

Week Ahead: US job data takes the spotlight

USD/CHF Price Forecast: Evaluating the 2026 Breakout Amid Fed and SNB Policy Divergence

SK Hynix Equity Analysis 2026: The Intersection of AI Memory Dominance and Valuation Arbitrage

Dow Advances on Value Rotation While Tech Sell-Off and Plunging Crude Drag S&P 500, Nasdaq Lower

FOMC June 2026: Warsh’s Hawkish Pivot and Forex Market Impact

Japan and South Korea Stocks Rebound as Nikkei Hits Fresh High and KOSPI Rises Over 1.5%

5 Ways South African Traders Can Capitalise on the SpaceX Listing Aftermath

Spot Gold Rebounds Above $4,000 as US Manufacturing Slows and Fed Shifts Messaging

Crude Oil Prices Extend Post-War Slump as Supply Risks Fade and Hormuz Traffic Rebounds

US Jobs Report Preview: Will June Payrolls Revive Fed Hike Bets?

Markets are carefully monitoring June US labor numbers today

Bitcoin Price Outlook: Could BTC Fall Toward $53,000 After Losing $60,000 Support?

Brent Holds Above $73 as Iran Talks Uncertainty Offsets Hormuz Recovery

Gold Price Today, July 1: Spot Gold Faces Worst Quarterly Loss in 13 Years

AMD Stock Hits Record High as AI Chip Optimism Lifts Semiconductor Sentiment